Evidence map›Paper›PMID 40640804›Full record

ArticleMicrobial cell factories2025

New Yarrowia lipolytica chassis strains for industrial enzyme production.

Djamila Onésime, Esteban Lebrun, Goran Stanajic Petrovic, Ewelina Celińska, Jean-Marc Nicaud

Abstract read
In one paragraph

Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Djamila OnésimeINRAE, AgroParisTech, Micalis Institute, UMR1319, Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France. djamila.onesime@inrae.fr.ORCID http://orcid.org/0000-0002-6020-6399
Esteban LebrunINRAE, AgroParisTech, Micalis Institute, UMR1319, Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France.ORCID http://orcid.org/0000-0002-8354-4673
Goran Stanajic PetrovicINRAE, AgroParisTech, Micalis Institute, UMR1319, Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France.ORCID http://orcid.org/0009-0005-9597-2463
Ewelina CelińskaDepartment of Biotechnology and Food Microbiology, Poznan University of Life Sciences, Ul. Wojska Polskiego 48, 60-637, Poznań, Poland.ORCID http://orcid.org/0000-0002-6679-972X
Jean-Marc NicaudINRAE, AgroParisTech, Micalis Institute, UMR1319, Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France.ORCID http://orcid.org/0000-0001-8372-8459

Funding

CIFRE from Sanofi R&D Department n°2019/1206National Science center, Poland 2021/41/B/NZ9/00086
6 · The paper itself

Abstract

backgroundYarrowia lipolytica has emerged as a well-established platform for producing a wide range of biomolecules, including recombinant proteins (rProteins). Its robust metabolism and resistance to various environmental stressors make it particularly well-suited as a microbial cell factory. However, additional physiological modifications are still required to fully meet industrial demands. Over years of strain development, Y. lipolytica has been engineered to carry auxotrophic markers, streamline the secretory pathway via deletion of native secretory proteins, prevent filamentation, and enable inducible gene expression systems.

resultsIn this study, we continued the fine-tuning of Y. lipolytica as a platform for rProtein synthesis, building on previous work. Specifically, we: (i) introduced a third auxotrophy to facilitate more complex genetic engineering strategies, (ii) removed bacterial vector elements (including antibiotic resistance genes) from previous constructs, and (iii) carried out extensive deletions of extracellular proteases and a peroxidase gene. The newly constructed chassis strains, JMY9438 and JMY9451/9452, both bear triple auxotrophies. The latter strain additionally lacks proteolytic activity due to the deletion of five protease genes. We evaluated the rProtein production efficiency of these strains harboring one, two or three integrated copies of the target gene. rProtein expression levels increased with copy number up to two; however, no further improvement was observed with three copies. Notably, the strain with protease deletions and a single gene copy showed the highest rProtein production per cell, while the strain retaining proteases but harboring two copies yielded the highest absolute rProtein levels.

conclusionsWe present a new generation of Y. lipolytica chassis strains specifically optimized for recombinant protein production. Our results demonstrate that extensive protease deletions can provide a high-performance genetic background, enabling high-level rProtein production without relying on multi-copy expression strategies.

Indexed as

Industrial MicrobiologyRecombinant ProteinsYarrowiaFungal ProteinsGene DeletionGenetic EngineeringFungal ProteinsRecombinant ProteinsChassis strainGlucoamylaseHybrid promoterMicrobial cell factoryProtein expressionRecombinant proteinTranscription factorYarrowia lipolytica

Identifiers

PMID40640804
PMCPMC12247380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.